Fluvoxamine Maleate

Product manufactured by Apotex Corp

Application Nr Approved Date Route Status External Links
ANDA075902 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Fluvoxamine Maleate Tablets Are Indicated For The Treatment Of Obsessions And Compulsions In Patients With Obsessive Compulsive Disorder (ocd) ( 1 ). 1.1 Obsessive-Compulsive Disorder Fluvoxamine Maleate Tablets Are Indicated For The Treatment Of Obsessions And Compulsions In Patients With Obsessive Compulsive Disorder (ocd), As Defined In Dsm-Iii-R Or Dsm-Iv. The Obsessions Or Compulsions Cause Marked Distress, Are Time-Consuming, Or Significantly Interfere With Social Or Occupational Functioning. Obsessive Compulsive Disorder Is Characterized By Recurrent And Persistent Ideas, Thoughts, Impulses Or Images (obsessions) That Are Ego-Dystonic And/or Repetitive, Purposeful, And Intentional Behaviors (compulsions) That Are Recognized By The Person As Excessive Or Unreasonable. The Efficacy Of Fluvoxamine Maleate Tablets Was Established In Four Trials In Outpatients With Ocd: Two 10-Week Trials In Adults, One 10-Week Trial In Pediatric Patients (ages 8 To 17), And One Maintenance Trial In Adults [see Clinical Studies ( 14 )].

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Fluvoxamine Maleate FLUVOXAMINE MALEATE ZINC3872605

Comments